Tocilizumab for rheumatoid arthritis
- PMID: 20040568
- DOI: 10.1136/dtb.2009.08.0033
Tocilizumab for rheumatoid arthritis
Abstract
Tocilizumab (RoActemra-Roche) is a new biological agent available in the UK for the treatment of adults with rheumatoid arthritis.1 Unlike currently available biological agents, the drug targets the pro-inflammatory cytokine interleukin-6 (IL-6). Here, we consider the place of tocilizumab in rheumatoid arthritis and whether it offers any advantages over other biological agents.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical